The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Structure-based drug design to augment hit discovery
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Docking and scoring in virtual screening for drug discovery: methods and applications
Kitchen, D. B., Decornez, H., Furr, J. R., & Bajorath, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1549 · Cited by 4,150
CASTp: Computed Atlas of Surface Topography of proteins
Binkowski, T. A. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg512 · Cited by 1,669
Virtual screening of chemical libraries
Shoichet, B. K. (2004) · Nature · doi:10.1038/nature03197 · Cited by 1,425
Krieger, E., Joo, K., Lee, J., Lee, J., Raman, S., Thompson, J., Tyka, M., Baker, D., & Karplus, K. (2009) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.22570 · Cited by 1,409
Protein structure homology modeling using SWISS-MODEL workspace
Bordoli, L., Kiefer, F., Arnold, K., Benkert, P., Battey, J., & Schwede, T. (2009) · Nature Protocols · doi:10.1038/nprot.2008.197 · Cited by 1,229
Hit and lead generation: beyond high-throughput screening
Bleicher, K. H., Böhm, H.-J., Müller, K., & Alanine, A. I. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1086 · Cited by 1,056
Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites
Laurie, A. T. R., & Jackson, R. M. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti315 · Cited by 1,047
Protein–ligand docking: Current status and future challenges
Sousa, S. F., Fernandes, P. A., & Ramos, M. J. (2006) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.21082 · Cited by 1,004
Computer-based de novo design of drug-like molecules
Schneider, G., & Fechner, U. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1799 · Cited by 948
The Process of Structure-Based Drug Design
Anderson, A. C. (2003) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.09.002 · Cited by 939
The computer program LUDI: A new method for the de novo design of enzyme inhibitors
B�hm, H.-J. (1992) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00124387 · Cited by 835
Combining docking and molecular dynamic simulations in drug design
Alonso, H., Bliznyuk, A. A., & Gready, J. E. (2006) · Medicinal Research Reviews · doi:10.1002/med.20067 · Cited by 759
INHIBITORS OF HIV-1 PROTEASE: A Major Success of Structure-Assisted Drug Design
Wlodawer, A., & Vondrasek, J. (1998) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.27.1.249 · Cited by 734
The influence of lead discovery strategies on the properties of drug candidates
Keserü, G. M., & Makara, G. M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2796 · Cited by 628
Virtual screening: an endless staircase?
Schneider, G. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3139 · Cited by 533
Huang, S.-Y., Grinter, S. Z., & Zou, X. (2010) · Physical Chemistry Chemical Physics · doi:10.1039/c0cp00151a · Cited by 508
LIGSITEcsc: predicting ligand binding sites using the Connolly surface and degree of conservation.
Huang, B., & Schroeder, M. (2006) · BMC Structural Biology · doi:10.1186/1472-6807-6-19 · Cited by 472
Doman, T. N., McGovern, S. L., Witherbee, B. J., Kasten, T. P., Kurumbail, R., Stallings, W. C., Connolly, D. T., & Shoichet, B. K. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010548w · Cited by 462
Cho, A. E., Guallar, V., Berne, B. J., & Friesner, R. (2005) · Journal of Computational Chemistry · doi:10.1002/jcc.20222 · Cited by 410
Recent advances in computer-aided drug design
Song, C. M., Lim, S. J., & Tong, J. C. (2009) · Briefings in Bioinformatics · doi:10.1093/bib/bbp023 · Cited by 344
CAVEAT: A program to facilitate the design of organic molecules
Lauri, G., & Bartlett, P. A. (1994) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00124349 · Cited by 266
Hit discovery and hit-to-lead approaches
Keserű, G. M., & Makara, G. M. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.06.016 · Cited by 256
Marshall, G. R. (1987) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.27.040187.001205 · Cited by 255
Kastritis, P. L., & Bonvin, A. M. J. J. (2010) · Journal of Proteome Research · doi:10.1021/pr9009854 · Cited by 245
Martin, Y. C. (2009) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-009-9303-2 · Cited by 237
Data integration: challenges for drug discovery
Searls, D. B. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1608 · Cited by 198
Ligand efficiency and fragment-based drug discovery
Bembenek, S. D., Tounge, B. A., & Reynolds, C. H. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2008.11.007 · Cited by 196
SPROUT: Recent developments in the de novo design of molecules
Gillet, V. J., Newell, W., Mata, P., Myatt, G., Sike, S., Zsoldos, Z., & Johnson, A. P. (1994) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00017a027 · Cited by 179
Pharmacophore-Based Virtual Screening
Sun, H. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708784049630 · Cited by 176
Influence of Protonation, Tautomeric, and Stereoisomeric States on Protein−Ligand Docking Results
ten Brink, T., & Exner, T. E. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci800420z · Cited by 173
Improving the hit-to-lead process: data-driven assessment of drug-like and lead-like screening hits
Wunberg, T., Hendrix, M., Hillisch, A., Lobell, M., Meier, H., Schmeck, C., Wild, H., & Hinzen, B. (2006) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03700-1 · Cited by 152
Muegge, I., & Oloff, S. (2006) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2006.12.002 · Cited by 138
A brief history of novel drug discovery technologies
Gershell, L. J., & Atkins, J. H. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1064 · Cited by 129
Recent advances and method development for drug target identification
Chan, J. N. Y., Nislow, C., & Emili, A. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.11.002 · Cited by 127
Krüger, D. M., & Evers, A. (2009) · ChemMedChem · doi:10.1002/cmdc.200900314 · Cited by 125
What has computer-aided molecular design ever done for drug discovery?
Clark, D. E. (2006) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.1.2.103 · Cited by 113
High-throughput andin silicoscreenings in drug discovery
Phatak, S. S., STEPHAN, C. C., & Cavasotto, C. N. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440903190961 · Cited by 112
Computer Applications in Pharmaceutical Research and Development
(2006) · Wiley eBooks · doi:10.1002/0470037237 · Cited by 100
Discovering Potent Small Molecule Inhibitors of Cyclophilin A Using de Novo Drug Design Approach
Ni, S., Yuan, Y., Huang, J. Y., Mao, X., Lv, M., Zhu, J., Shen, X., Pei, J., Lai, L., Jiang, H., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9008295 · Cited by 96
A perspective of publicly accessible/open-access chemistry databases
Williams, A. J. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.03.017 · Cited by 69
Temperini, C., Cecchi, A., Scozzafava, A., & Supuran, C. T. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.12.023 · Cited by 69
Rutenber, E. E., & Stroud, R. M. (1996) · Structure · doi:10.1016/s0969-2126(96)00139-6 · Cited by 67
Computer Applications In Pharmaceutical Research And Development
Ekins, S. (2017) · Cited by 60
Hit and lead identification: Integrated technology-based approaches
Goodnow, R. A. (2006) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2006.12.009 · Cited by 44
Targeting Protein Multiple Conformations: A Structure-Based Strategy for Kinase Drug Design
Jeffrey, L., & Robert, A. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607781696783 · Cited by 37
Docking compared to 3D-pharmacophores: the scoring function challenge
Hein, M., Zilian, D., & Sotriffer, C. (2010) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2010.12.003 · Cited by 37
Potapov, V., Cohen, M., Inbar, Y., & Schreiber, G. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-374 · Cited by 28
wwLigCSRre: a 3D ligand-based server for hit identification and optimization
Spérandio, O., Petitjean, M., & Tufféry, P. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp324 · Cited by 25
Receptor Flexibility for Large-Scale In Silico Ligand Screens
Fischer, B., Merlitz, H., & Wenzel, W. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-177-2_18 · Cited by 7
Cited by
Molecular Docking and Structure-Based Drug Design Strategies
Ferreira, L., Dos Santos, R., Oliva, G., & Andricopulo, A. (2015) · Molecules · doi:10.3390/molecules200713384 · Cited by 2,528
Computational Methods in Drug Discovery
Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007336 · Cited by 2,160
Role of computer-aided drug design in modern drug discovery
Macalino, S. J. Y., Gosu, V., Hong, S., & Choi, S. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0640-5 · Cited by 762
A Structure-Based Drug Discovery Paradigm
Batool, M., Ahmad, B., & Choi, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112783 · Cited by 744
In silico methods and tools for drug discovery
Shaker, B., Ahmad, S., Lee, J., Jung, C., & Na, D. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104851 · Cited by 607
Metadata
- Authors
- Kalyaanamoorthy, S., & Chen, Y.-P. P.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 16
- Issue
- 17-18
- Pages
- 831-839
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2021552823
- Cited by
- 296
- References
- 49
- FWCI
- 12.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.